Is it appropriate to prescribe Adderall (mixed amphetamine salts) to a 71‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prescribing Adderall to a 71-Year-Old Woman Requires Extreme Caution and Is Generally Not Recommended

Adderall has not been studied in the geriatric population, and prescribing stimulants to older adults carries significant cardiovascular and other risks that must be carefully weighed against potential benefits 1.

Key Considerations Before Prescribing

1. Establish a Clear Diagnosis

  • Confirm ADHD diagnosis with symptoms present before age 7 and causing impairment in at least two settings 1
  • Rule out other causes of inattention in older adults:
    • Cognitive decline/dementia
    • Depression or anxiety
    • Medication side effects
    • Sleep disorders
    • Thyroid dysfunction

2. Assess Absolute Contraindications

The following conditions prohibit stimulant use 2:

  • Symptomatic cardiovascular disease (angina, heart failure, arrhythmias)
  • Hypertension (especially uncontrolled)
  • Glaucoma
  • Hyperthyroidism
  • Active psychotic disorder
  • History of stimulant abuse
  • Concurrent MAO inhibitor use

3. Evaluate Cardiovascular Risk

This is critical in a 71-year-old patient. Amphetamines increase systolic blood pressure by 1.93 mmHg and diastolic by 1.84 mmHg, with heart rate increasing by 3.71 beats per minute 3. The ACC/AHA guidelines specifically list amphetamines as medications that may cause elevated blood pressure and recommend discontinuation or dose reduction 4, 5.

Required cardiovascular assessment:

  • Blood pressure and pulse (must be normal and controlled)
  • Personal history of cardiac disease, stroke, or arrhythmias
  • Family history of sudden cardiac death or early cardiovascular disease
  • ECG if any cardiac concerns (though not routinely required) 6

4. Consider Age-Related Pharmacokinetic Changes

Older adults experience 7:

  • Reduced renal and hepatic clearance (higher drug levels)
  • Increased body fat (altered drug distribution)
  • Altered end-organ responsiveness
  • Greater risk of adverse drug events

Safer Alternative Approaches

If ADHD treatment is truly necessary in this patient, consider:

  1. Non-stimulant medications first:

    • Atomoxetine (norepinephrine reuptake inhibitor) - uncontrolled substance with lower cardiovascular risk 8
    • Alpha-2 agonists (guanfacine, clonidine) - may actually lower blood pressure 8
  2. Behavioral interventions:

    • Cognitive behavioral therapy
    • Environmental modifications
    • Organizational strategies

If Stimulants Are Absolutely Required

Start with the lowest possible dose and monitor intensively:

  • Begin with 5 mg once daily (half the typical starting dose) 2
  • Check blood pressure and pulse before starting and at every visit 2
  • Monitor for:
    • Cardiovascular symptoms (chest pain, palpitations, syncope)
    • Psychiatric symptoms (anxiety, agitation, psychosis)
    • Sleep disturbances
    • Appetite suppression/weight loss
    • Peripheral vasculopathy (numbness, color changes in fingers/toes) 1

Critical Warnings

Withdrawal due to adverse effects is 2.69 times more likely with amphetamines versus placebo 3. Common adverse effects include 1:

  • Decreased appetite
  • Insomnia
  • Nervousness
  • Dry mouth
  • Cardiovascular effects

The Beers Criteria does not specifically list stimulants as potentially inappropriate in older adults 9, but the lack of geriatric studies and known cardiovascular risks make this a high-risk prescription.

Documentation Requirements

Document thoroughly 2:

  • Rationale for stimulant use over alternatives
  • Cardiovascular assessment findings
  • Discussion of risks with patient
  • Baseline vital signs and weight
  • Plan for ongoing monitoring

The safest approach is to avoid stimulants in this age group unless there is compelling evidence of severe ADHD causing significant functional impairment, no cardiovascular contraindications exist, and non-stimulant options have failed.

References

Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Research

Effect of amphetamines on blood pressure.

The Cochrane database of systematic reviews, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.